LEMBOREXANT - Food and Drug Administration

Set ID
3abc7c72-d84e-445a-b0eb-9dffce7056b8
Type
Indexing - product concept
Effective date
2020-06-05
Version
1
Source
DailyMed source

Mapped DailyMed Labels#

Label, Relation, Manufacturer table
LabelRelationManufacturerEffective
These highlights do not include all the information needed to use DAYVIGO ® safely and effectively. See full prescribing information for DAYVIGO ® . DAYVIGO ® (lemborexant) tablets, for oral use, CIV Initial U.S. Approval: 2019Product nameEisai Inc. | Eisai Co., Ltd. | Eisai Manufacturing Ltd | Pace Analytical Life Sciences, LLC | Pharma Packaging Solutions, LLC dba Tjoapack, LLC2025-02-24